Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
KSL Biomedical Logo
KSL Biomedical Growth Score
89
CB Rank
355876
Heat Score
64
KSL Biomedical is a developers of novel companion diagnostic and therapeutic applications for immunology and oncology.
Founded
obfuscation
Private Buffalo, New York, United States101-250 www.kslbiomedical.com/
Biotechnology
Health Care
Oncology
Therapeutics
Overview

KSL Biomedical
Growth Score
89
Heat Score
64

Growth Score89
2 pts
in past quarter
Heat Score 64
26 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About KSL Biomedical

CB Rank
355876
KSL Biomedical is a developers of novel companion diagnostic and therapeutic applications for immunology and oncology.
Founded
obfuscation
Private Buffalo, New York, United States101-250 www.kslbiomedical.com/
Biotechnology
Health Care
Oncology
Therapeutics

Details

Operating Status Active
Company Type For Profit
About the Company
KSL Biomedical is a developers of novel companion diagnostic and therapeutic applications for immunology and oncology.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

RPR Carbon Antigen Rapid Test Kits and Solution
FDA-approved rapid test kits and solutions for screening non-treponemal antibodies related to syphilis.
Diagnostic and Therapeutic Applications for Immunology and Oncology
Development of novel companion diagnostic and therapeutic technologies targeting immunology and oncology conditions.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Contacts 5
News

News and Press

News•Dec 21, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 27, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

286

IT Spend

$328.3KThis year, KSL Biomedical is projected to spend $328.3K on IT, according to Aberdeen.

Active Website Tech Count

39KSL Biomedical is actively using 39 technologies for its website, according to BuiltWith. These include SSL by Default, LetsEncrypt, and  Apple Mobile Web Clips Icon.
Sub-Organizations

Sub-Organizations

Number of Sub-Orgs 1
Which industries do these Sub-Organization operate in?
Pulse Scientific Logo
Pulse ScientificSubsidiary
Frequently Asked Questions

Where is KSL Biomedical's headquarters? KSL Biomedical is located in Buffalo, New York, United States.Who are KSL Biomedical's competitors? Alternatives and possible competitors to KSL Biomedical may include Abbott, BD, and  Bio-Rad Laboratories.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f7db04b 1)
|